Colombia faces shortage of pediatric HIV drugs as sole manufacturer halts production

Three essential pediatric HIV prevention and treatment medicines, produced by a single manufacturer, are running out in Colombia after production ceased. The shortage threatens continuity of care for children living with or exposed to HIV, with no clear timeline for resupply. This is a supply-chain vulnerability in a critical public-health program, though the cause of the production halt is not specified.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works